BOSTON--(BUSINESS WIRE)--March 29, 2006--Proteome Systems (ASX:PXL) today announced that its international partner, the Foundation for Innovative New Diagnostics (FIND), has signed off on the second Milestone in its Tuberculosis (TB) diagnostic program, saying it is on track for the development of a rapid point-of-care (POC) test to control the spread of TB in emerging and developed nations.
